Wegovy: Abnehmtablette kommt in deutsche Apotheken
Die Abnehmspritze gibt es in Deutschland schon länger. Ab Dienstag gibt es das Diätmittel auch in Form von Tabletten. Was Interessierte jetzt wissen müssen.
For the first time, a medication known as Wegovy, a GLP-1 drug used for weight loss, will be available in German pharmacies in tablet form. Previously, the medication, containing the active ingredient Semaglutide, was marketed as an injectable solution under the brand name Wegovy. Key points regarding the upcoming availability of Wegovy tablets in Germany include the planned market launch date of September 1st, announced by a spokesperson from Danish pharmaceutical company Novo Nordisk to the German Press Agency.
Novo Nordisk, which also produces Wegovy injectable formulations, stated they have sufficient stock to meet anticipated demand.
The European Union granted approval for Wegovy tablets in July. Apothecaries are preparing for high demand, with President Thomas Preis of the German Pharmacy Association Association (ABDA) confirming pharmacies will be well-stocked starting September 1st, contingent on timely delivery of adequate stock from the manufacturer. Crucial aspects to discuss with patients include proper usage, potential side effects, and unique aspects of the medication.
German physicians, such as Markus Blumenthal-Beier, president of the Board of the House Physicians Association, noted that weight loss medications are a significant concern among patients. He emphasized the importance of direct patient consultations to educate them on eligibility, risks, and side effects.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
